Eversept Partners’s Terns Pharmaceuticals TERN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q3
Sell
-286,266
Closed -$1.95M 80
2024
Q2
$1.95M Buy
286,266
+3,232
+1% +$22K 0.13% 63
2024
Q1
$1.86M Buy
+283,034
New +$1.86M 0.12% 61